Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2025 Feb 3;46(5):473-483.
doi: 10.1093/eurheartj/ehae742.

Clinical risk prediction, coronary computed tomography angiography, and cardiovascular events in new-onset chest pain: the PROMISE and SCOT-HEART trials

Affiliations
Randomized Controlled Trial

Clinical risk prediction, coronary computed tomography angiography, and cardiovascular events in new-onset chest pain: the PROMISE and SCOT-HEART trials

Laust Dupont Rasmussen et al. Eur Heart J. .

Abstract

Background and aims: Whether index testing using coronary computed tomography angiography (CTA) improves outcomes in stable chest pain is debated. The risk factor weighted clinical likelihood (RF-CL) model provides likelihood estimation of obstructive coronary artery disease. This study investigated the prognostic effect of coronary CTA vs. usual care by RF-CL estimates.

Methods: Large-scale studies randomized patients (N = 13 748) with stable chest pain to coronary CTA as part of the initial work-up in addition to or instead of usual care including functional testing. Patients were stratified according to RF-CL estimates [RF-CL: very-low (≤5%), low (>5%-15%), and moderate/high (>15%)]. The primary endpoint was myocardial infarction or death at 3 years.

Results: The primary endpoint occurred in 313 (2.3%) patients. Event rates were similar in patients allocated to coronary CTA vs. usual care [risk difference (RD) 0.3%, hazard ratio (HR) 0.84 (95% CI 0.67-1.05)]. Overall, 33%, 44%, and 23% patients had very-low, low, and moderate/high RF-CL. Risk was similar in patients with very low and moderate/high RF-CL allocated to coronary CTA vs. usual care [very low: RD 0.3%, HR 1.27 (0.74-2.16); moderate/high: RD 0.5%, HR 0.88 (0.63-1.23)]. Conversely, patients with low RF-CL undergoing coronary CTA had lower event rates [RD 0.7%, HR 0.67 (95% CI 0.47-0.97)]. The number needed to test using coronary CTA to prevent one event within 3 years was 143.

Conclusions: Despite an overall good prognosis, low RF-CL patients have reduced risk of myocardial infarction or death when allocated to coronary CTA vs. usual care. Risk is similar in patients with very-low and moderate/high likelihood.

Keywords: Chronic coronary syndrome; Clinical likelihood; Coronary computed tomography angiography; Pre-test probability.

PubMed Disclaimer

Figures

Structured Graphical Abstract
Structured Graphical Abstract
The risk factor-weighted clinical likelihood denotes patient-specific procentual estimates on probability of having obstructive coronary artery disease (CAD) at invasive cornary angiography. In the table, blue, green and yellow colours denote patients with ≤5%, 5%–≤15%, and >15% clinical likelihood of obstructive CAD at invasive coronary angiography, respectively. CTA, computed tomography angiography.
Figure 1
Figure 1
Cumulative incidence of myocardial infarction and death stratified by (A) randomisation, (B) RF-CL groups, and (C) randomisation and RF-CL groups. In total, 4483 (32.7%), 6093 (44.4%), and 3135 (22.9%) patients were grouped as RF-CL ≤5%, RF-CL >5%–≤15%, and RF-CL >15%, respectively. Abbreviations: RF-CL, risk factor-weighted clinical likelihood; CTA, computed tomography angiography.
Figure 2
Figure 2
Change in lipid-lowering therapy from baseline to 8 weeks. Data presented for the 11,465/13,711 (83.6%) patients in whom an RF-CL estimate was calculated, and information on test abnormality and lipid-lowering therapy during follow-up was available. Patients without an index test were considered to have a normal test results. Abbreviations: RF-CL, risk factor-weighted clinical likelihood; CTA, computed tomography angiography.
Figure 3
Figure 3
Change in antiplatelet therapy from baseline to 8 weeks. Data presented for the 10 996/13 711 (80.2%) patients in whom an RF-CL estimate was calculated, and information on test abnormality and antiplatelet therapy during follow-up was available. Patients without an index test were considered to have a normal test results. Abbreviations: RF-CL, risk factor-weighted clinical likelihood; CTA, computed tomography angiography.
Figure 4
Figure 4
Revascularisation within 90 days. Data presented for the 12 979/13 711 (94.7%) patients in whom an RF-CL estimate was calculated, and information on test abnormality and revascularisation was available. Patients without an index test were considered to have a normal test results. Abbreviations: RF-CL, risk factor-weighted clinical likelihood; CTA, computed tomography angiography.

References

    1. Douglas PS, Hoffmann U, Patel MR, Mark DB, Al-Khalidi HR, Cavanaugh B, et al. Outcomes of anatomical versus functional testing for coronary artery disease. N Engl J Med 2015;372:1291–300. 10.1056/NEJMoa1415516 - DOI - PMC - PubMed
    1. SCOT-HEART Investigators . CT coronary angiography in patients with suspected angina due to coronary heart disease (SCOT-HEART): an open-label, parallel-group, multicentre trial. Lancet 2015;385:2383–91. 10.1016/S0140-6736(15)60291-4 - DOI - PubMed
    1. SCOT-HEART Investigators Newby DE, Adamson PD, Berry C, Boon NA, Dweck MR, et al. Coronary CT angiography and 5-year risk of myocardial infarction. N Engl J Med 2018;379:924–33. 10.1056/NEJMoa1805971 - DOI - PubMed
    1. Berry C, Kramer CM, Kunadian V, Patel TR, Villines T, Kwong RY, et al. Great debate: computed tomography coronary angiography should be the initial diagnostic test in suspected angina. Eur Heart J 2023;44:2366–75. 10.1093/eurheartj/ehac597 - DOI - PMC - PubMed
    1. Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, et al. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 2019;41:407–77. 10.1093/eurheartj/ehz425 - DOI - PubMed

Publication types